Aspirin resistance in patients with acute coronary syndrome. Part 1

QR Code

Aspirin resistance in patients with acute coronary syndrome. Part 1

Aim. To evaluate the prevalence of aspirin resistance, its clinical features, potential solutions, and prognostic role in patients with acute coronary syndrome (ACS). Material and methods. The study included 51 patients with ACS and ST segment elevation (STEACS) and 49 ACS patients without ST segmen...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. S. Frolova, R. M. Shakhnovich, E. M. Kaznacheeva, O. V. Sirotkina, A. B. Dobrovolsky
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2010-12-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	acetylsalicylic acid aspirin resistance acute coronary syndrome platelet aggregation inflammation markers genetic polymorphisms
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2143
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Aspirin resistance in patients with acute coronary syndrome. Part 2
by: N. S. Frolova, et al.
Published: (2011-04-01)

ASPIRIN RESISTANCE CANDIDATE GENES AND THEIR ASSOCIATION WITH THE RISK OF CARDIOVASCULAR EVENTS
by: Yu. I. Grinshtein, et al.
Published: (2013-02-01)

ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION
by: D. H. Ainetdinova, et al.
Published: (2016-01-01)

HEMOSTASIS AND FUNCTIONAL PROPERTIES OF NEUTROPHILS IN PATIENTS WITH VARIOUS SENSITIVITY TO ACETYLSALICYLIC ACID IN ACUTE CORONARY SYNDROME
by: I. Yu. Grinshtein, et al.
Published: (2015-10-01)

TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN
by: A. I. Martynov, et al.
Published: (2015-09-01)

Aspirin Resistance as a Result of Impaired Interaction of Platelets and Neutrophils in Patients with Coronary Heart Disease
by: M. D. Goncharov, et al.
Published: (2021-03-01)

Antiaggregant influence on platelet aggregation in patients with acute coronary syndrome without ST segment elevation
by: T. M. Poponina, et al.
Published: (2006-10-01)

COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE
by: N. A. Belolipetskiy, et al.
Published: (2016-01-01)

CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES
by: P. J. Dovgalevsky, et al.
Published: (2016-01-01)

Possibility of application of low-frequency piezothromboelastografy method for the evaluation of haemostatic potential of blood in coronary bypass surgery on the background of long aspirinotherapy
by: Elena V. Fanaskova, et al.
Published: (2017-10-01)

ASPIRIN IN THE PREVENTION OF ATHEROTHROMBOSIS AND CORONARY HEART DISEASE
by: M. G. Bubnova
Published: (2010-08-01)

EVALUATION OF ASPIRIN USAGE SAFETY IN CORONARY BYPASS SURGERY
by: A. M. Chernyavsky, et al.
Published: (2017-10-01)

Efficacy of buffered and enteric-coated acetylsalicylic acid on platelet aggregation in patients with stable coronary artery disease and type 2 diabetes (CASCADE): rationale and design of a single-center observational comparative study
by: Zh. D. Kobalava, et al.
Published: (2025-02-01)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01)

Aspirin-induced gastrointestinal lesions in patients with chronic coronary artery disease: special aspects and therapeutic options
by: N. Yu. Borovkova, et al.
Published: (2020-04-01)

Efficacy of buffered acetylsalicylic acid and enteric-coated acetylsalicylic acid on platelet aggregation in patients with chronic coronary syndrome and type 2 diabetes (CASCADE): single-center observational comparative study
by: Zh. D. Kobalava, et al.
Published: (2025-03-01)

Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome
by: I. Yu. Grinshtein, et al.
Published: (2016-11-01)

Monitoring of Aspirin Therapy in Patients with Cerebrovascular Pathology
by: M. M. Tanashyan, et al.
Published: (2021-09-01)

The effect of single and dual antiplatelet therapy on the activity of pro-inflammatory cytokines in patients with coronary artery disease and obstructive sleep apnea
by: V. I. Ruzov, et al.
Published: (2020-04-01)

DYNAMICS OF HEMOSTASIS AND NEUTROPHIL FUNCTIONAL ACTIVITY CHANGES IN PATIENTS WITH VARIOUS SENSITIVITY TO ACETYLSALICYLIC ACID IN ACUTE MYOCARDIAL INFARCTION
by: I. Yu. Grinshtein, et al.
Published: (2016-08-01)

EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: A. L. Alyavi, et al.
Published: (2016-01-01)

Platelet functions in healthy persons with genetic polymorphisms gpia(с807т), gpiiia(т1565с), gpipa(с434т), p2ry12(н1/н2), selp(-g1087a) platelet receptions
by: N. N. Strambovskaya
Published: (2013-11-01)

ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID
by: I. N. Bokarev, et al.
Published: (2016-01-01)

Double antiplatelet therapy in patients with acute coronary syndrome
by: A. V. Rodionov, et al.
Published: (2011-10-01)

Aspirin vs. P2Y12 Inhibitor Rivalry: Which One Can be Continued During Gastrointestinal Bleeding
by: Muhammad Begawan Bestari, et al.
Published: (2019-11-01)

Aspirin vs. P2Y12 Inhibitor Rivalry: Which One Can be Continued During Gastrointestinal Bleeding
by: Muhammad Begawan Bestari, et al.
Published: (2019-11-01)

Study of the Association of V640L (rs6133) Polymorphism in the Platelet P-selectin Gene with Acetylsalicylic Acid Resistance in Patients after Coronary Bypass Surgery
by: A. A. Kosinova, et al.
Published: (2019-07-01)

ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2
by: E. V. Gorjacheva, et al.
Published: (2016-01-01)

New perspectives in immunological diagnostics of coronary heart disease
by: S. I. Davydov, et al.
Published: (2012-02-01)

Study of pharmaceutical properties of low-dosage enteric-coated acetylsalicylic acid
by: V. V. Rafalsky, et al.
Published: (2016-02-01)

COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR)
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

GENOTYPE -786CC OF THE ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE NOS3 AS A FACTOR OF ADVERSE CORONARY HEART DISEASE COURSE AND INCREASED ON-TREATMENT PLATELET AGGREGATION
by: E. F. Muslimova, et al.
Published: (2017-11-01)

CLOPIDOGREL FOR SELECTIVE MYOCARDIAL REVASCULARIZATION
by: N. V. Teplova
Published: (2016-03-01)

GENETIC MARKERS OF NEGATIVE OUTCOMES OF THE ACUTE CORONARY SYNDROME
by: N. G. Lozhkina, et al.
Published: (2014-10-01)

ANTIAGGREGANT THERAPY AND REDUCTION OF HIGH RESIDUAL PLATELET REACTIVITY
by: N. A. Mazur, et al.
Published: (2012-08-01)

Aspirin effectiveness in patients with rheumatoid arthritis and coronary heart disease who receive non-steroidal anti-inflammatory drugs
by: T. V. Kropotina, et al.
Published: (2013-04-01)

Molecular and metabolic characteristics of changes in the platelet sensitivity to antiplatelet therapy in patients with coronary artery disease before and after coronary artery bypass grafting
by: M. D. Goncharov, et al.
Published: (2021-07-01)

Effect of aspirin on platelet-rich plasma of diabetes mellitus with lower extremity atherosclerosis
by: Jiajia Zhang, et al.
Published: (2024-12-01)

Genetic predictors of five-year outcomes of acute coronary syndrome
by: N. G. Lozhkina, et al.
Published: (2019-11-01)

RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS
by: A. A. Lomonosova, et al.
Published: (2015-12-01)